250 Real-World Efficacy Data on First-Line Atezolizumab Plus Chemotherapy in Extensive Small Cell Lung Cancer (ES-SCLC): A Multi-Centre Retrospective Analysis from University Hospitals Birmingham NHS Trust and Worcester Acute Hospitals NHS Trust | AMiner
250 Real-World Efficacy Data on First-Line Atezolizumab Plus Chemotherapy in Extensive Small Cell Lung Cancer (ES-SCLC): A Multi-Centre Retrospective Analysis from University Hospitals Birmingham NHS Trust and Worcester Acute Hospitals NHS Trust